Corporate divestitures, November 2025
Completed sales and spin-offs of business units disclosed in SEC 8-K filings during November 2025. Every row links to its filing.
Every completed divestiture filed this month.
| Filed | Seller | Business sold | Buyer | Disclosed value | Seller sector | Filing |
|---|---|---|---|---|---|---|
| 2025-11-03 | GOODYEAR TIRE & RUBBER CO /OH/ (GT) | Goodyear polymer chemical businessWhat the filing says"On October 31, 2025, The Goodyear Tire & Rubber Company, an Ohio corporation (the " Company "), completed the previously announced sale of its polymer chemical business (the " Business ") to G-3 Chickadee Purchaser, LLC, a Delaware limited liability company (the " Purchaser "), for a purchase price of $650 million, subject to adjustments in accordance with the terms of the Asset Purchase Agreement dated as of May 22, 2025 (as amended, the " Agreement "), by and between the Company and the Purchaser (the " Transacti" | G-3 Chickadee Purchaser, LLC | $650M | Industrials | SEC 8-K |
| 2025-11-17 | Semilab International Zrt. | Semilab USA LLCWhat the filing says"On November 17, 2025, Onto Innovation Inc. (the "Company") completed the previously announced acquisition of Semilab USA LLC ("Semilab USA"), pursuant to the Equity Purchase Agreement (the "Purchase Agreement"), dated as of June 27, 2025, by and among the Company, Semilab International Zrt. (the "Seller"), Semilab Zrt. and Semilab USA, as amended by the Amendment to Equity Purchase Agreement, dated October 9, 2025." | Onto Innovation Inc. | $495M | Industrials | SEC 8-KFiled by the buyer |
| 2025-11-24 | Marigold Group, Inc. | Marigold Enterprise BusinessWhat the filing says"Zeta Global Increases 2025 and 2026 Guidance following the Completion of the Marigold Acquisition NEW YORK-November 24, 2025 -Zeta Global (NYSE: ZETA), the AI marketing cloud, today announced it has increased 2025 and 2026 guidance following the completion of its acquisition of Marigold's enterprise software business, including Marigold Loyalty, Cheetah Digital, Selligent, Sailthru, Liveclicker, and Grow." | Zeta Global Holdings Corp. | $325M | Technology | SEC 8-K exhibitFiled by the buyer |
| 2025-11-03 | TOMPKINS FINANCIAL CORP (TMP) | Tompkins Insurance Agencies, Inc.What the filing says"On October 31, 2025, Tompkins Financial Corporation (the "Company"), Tompkins Insurance Agencies, Inc. ("TIA"), a wholly-owned subsidiary of the Company, and Arthur J. Gallagher Risk Management Services, LLC, an affiliate of Arthur J. Gallagher & Co. (collectively, "Gallagher") entered into a definitive stock purchase agreement (the "Purchase Agreement"), pursuant to which the Company sold all of the issued and outstanding shares of capital stock of TIA to Gallagher for a purchase price of $223,000,000, subject to " | Arthur J. Gallagher & Co. | $223M | Financials | SEC 8-K |
| 2025-11-25 | Lazydays Holdings, Inc. (GORV) | Lazydays RV dealerships (Portland, Knoxville, Council Bluffs, Tucson)What the filing says"On November 19, 2025, the Sellers closed the Asset Sales with respect to the Company's Sites in Portland, Oregon, Knoxville, Tennessee (other than with respect to the applicable Sellers' Knoxville, Tennessee owned real property), Council Bluffs, Iowa and Tucson, Arizona." | CIRV Group, LLC | $58.6M | Consumer and retail | SEC 8-K |
| 2025-11-04 | LifeMD, Inc. (LFMD) | WorkSimpli Software LLCWhat the filing says"LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services and pharmacy, today announced the sale of its majority ownership interest in WorkSimpli Software LLC ("WorkSimpli") in a transaction valuing WorkSimpli at an enterprise value of approximately $65 million." | Lion Buyer, LLC | $24M | Healthcare | SEC 8-K exhibit |
| 2025-11-07 | Biofrontera Inc. (BFRI) | Xepi (ozenoxacin) cream product assetsWhat the filing says"WOBURN, Mass. (November 7, 2025) - Biofrontera Inc. (Nasdaq: BFRI) ("Biofrontera" or the "Company") , a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT), today announced that it has divested its US license for Xepi ® (ozenoxacin) Cream, 1% to Pelthos Therapeutics Inc. Biofrontera received $3 million at closing, and is to receive an additional $1 million upon availability of commercial product, and up to $6 million in milestone payments, with $3 million ea" | Pelthos Therapeutics Inc. | $3M | Healthcare | SEC 8-K exhibit |
| 2025-11-06 | QSC, LLC | QSC Digital Cinema Speaker Series (DCS) product lineWhat the filing says"Moving iMage Technologies, Inc. (NYSE American: MITQ) ("MiT"), a leading provider of cutting-edge out-of-home entertainment technology and services for cinema, Esports, stadiums and arenas, has acquired the assets of the globally recognized Digital Cinema Speaker Series ( DCS ) loudspeaker product line from QSC." | Moving iMage Technologies, Inc. | $1.5M | Technology | SEC 8-K exhibitFiled by the buyer |
| 2025-11-28 | Damon Inc. (DMNIF) | Grafiti LimitedWhat the filing says"Pursuant to the Agreement, the Company sold to the Buyer, and the Buyer purchased from the Company, all of the issued and outstanding shares (the "Shares") of Grafiti Limited, a private company limited by shares incorporated in England and Wales ("Grafiti UK")." | Grafiti LLC | $120K | Industrials | SEC 8-K |
| 2025-11-03 | DuPont de Nemours, Inc. (DD) | Spin-off: Qnity Electronics, Inc.What the filing says"DuPont (NYSE: DD) announced today that it completed the separation of its electronics business into an independent public company, Qnity Electronics, Inc. ("Qnity"), on November 1, 2025." | Not named in this filing | Not disclosed | Materials and chemicals | SEC 8-K exhibit |
| 2025-11-10 | Mallinckrodt plc | Spin-off: Par Health, Inc.What the filing says"Mallinckrodt plc ("Mallinckrodt") today announced the completion of the planned spin-off of its Par Health generic pharmaceuticals and sterile injectables businesses." | Not named in this filing | Not disclosed | Healthcare | SEC 8-K exhibit |
Added on 2026-10-11 from the 93 Item 2.01 filings of the month, each read and classified by hand. Values are as stated in the filing, before adjustments.
November 2025 by sector.
| Seller sector | Divestitures | With a disclosed value | Disclosed value |
|---|---|---|---|
| Industrials | 3 | 3 | $1.15bn |
| Healthcare | 3 | 2 | $27M |
| Technology | 2 | 2 | $327M |
| Financials | 1 | 1 | $223M |
| Consumer and retail | 1 | 1 | $58.6M |
| Materials and chemicals | 1 | 0 | $0 |
What counts, and where it comes from.
A row is a completed sale or spin-off of a business unit (a business, segment, division or named subsidiary) reported in a Form 8-K filed with the SEC during the month (or, on a weekly page, the ISO week, Monday to Sunday): under Item 2.01, completion of acquisition or disposition of assets, or in a press release attached to the filing that says the sale has closed.
Sales of buildings, loan books or securities are left out, as is the sale of a whole company. Seller, buyer and value come from the filing, and each row keeps a sentence from it and a link to it. Where a filing does not name the buyer or the price, the table says so rather than filling the gap. The sector is the seller's SEC industry code, not the unit's; where the seller has none (a private or foreign parent, named in a filing made by the buyer), it is the sector of the business sold.
Weekly pages start in September 2026. The months from January 2025 to April 2026, and some deals in later months, were added in October 2026 from every Item 2.01 filing in that window, read and classified by hand rather than by the weekly search.
Source: SEC EDGAR full-text search and the filings themselves. Public filings only. None of these transactions is an FIH.com mandate, and nothing here is advice.
Planning a carve-out of your own?
The filings show what closed. The work that decides the price happens months earlier: the perimeter, the standalone numbers and the transition services.
Every mandate startswith one conversation.
Tell us what you are considering. A senior advisor from FIH will come back with a straight read on value, timing and who would actually buy it, before you commit to anything.
- Confidential. Nothing you share leaves the advisory team.
- Success-based. No retainer, no upfront fees, no obligation.
- A senior FIH advisor responds within one business day.